2000
DOI: 10.1074/jbc.275.3.1787
|View full text |Cite
|
Sign up to set email alerts
|

Thyroid Hormone-independent Interaction between the Thyroid Hormone Receptor β2 Amino Terminus and Coactivators

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
43
0

Year Published

2001
2001
2017
2017

Publication Types

Select...
7
2

Relationship

2
7

Authors

Journals

citations
Cited by 72 publications
(45 citation statements)
references
References 44 publications
2
43
0
Order By: Relevance
“…Interestingly, the N-terminal domain of TR␤2, but not of TR␤1 or TR␣1, can also interact in a hormone-independent manner with a Gln-rich region located near the C terminus of all three p160 coactivators (30,32). This coactivator interaction likely contributes to the in vivo ability of TR␤2 to activate target gene expression in the absence of T 3 (32).…”
Section: The Unique N Terminus Of Tr␤2 Is Essential For the Enhanced mentioning
confidence: 99%
“…Interestingly, the N-terminal domain of TR␤2, but not of TR␤1 or TR␣1, can also interact in a hormone-independent manner with a Gln-rich region located near the C terminus of all three p160 coactivators (30,32). This coactivator interaction likely contributes to the in vivo ability of TR␤2 to activate target gene expression in the absence of T 3 (32).…”
Section: The Unique N Terminus Of Tr␤2 Is Essential For the Enhanced mentioning
confidence: 99%
“…Alternative promoter usage and differential splicing have been observed for many transcription factor genes, and in several instances this alters the structure of an activation domain. Most similar to SREBP-1, alternative promoters that result in N-terminal heterogeneity are common in the nuclear receptor family where different versions of an N-terminal constitutive activation domain (AF1) are produced (Zhu et al 1995;Oberste-Berghaus et al 2000;Huber et al 2002). However, in most cases, the real physiological significance of these variants has not been fully explored because most studies have focused on the nuclear receptor AF2 activation domain, which is located close to the ligand-binding domain at the C terminus.…”
Section: Transcriptional Activation By Srebpsmentioning
confidence: 99%
“…Mutagenesis studies (21,22) suggest that TR DNA binding to the half-site is required for negative regulation. Activation of these nTRE in the absence of T 3 is mediated by the N terminus of TR-␤2 via a mechanism involving binding of coactivator proteins (23,24).In contrast, some investigators have suggested that TR DNA binding is not required for negative regulation. This mechanism has been proposed to explain negative regulation of the TSH-␣ promoter where an nTRE has not been clearly identified (25,26).…”
mentioning
confidence: 99%
“…Mutagenesis studies (21,22) suggest that TR DNA binding to the half-site is required for negative regulation. Activation of these nTRE in the absence of T 3 is mediated by the N terminus of TR-␤2 via a mechanism involving binding of coactivator proteins (23,24).…”
mentioning
confidence: 99%